How to Lower Blood Pressure According to Guidelines

What Lowers Blood Pressure the Most

The largest drops in the 2017 ACC/AHA table come from the DASH eating pattern (about 11 mmHg systolic in people with hypertension), cutting sodium (5 to 6 mmHg), losing weight (about 1 mmHg per kg lost), aerobic exercise (5 to 8 mmHg), isometric exercise (about 5 mmHg) and cutting alcohol (about 4 mmHg). None of the sources cited here supports a 60-second breathing trick. A reading of 180/120 mmHg or higher with symptoms such as chest pain, headache or vision changes is an emergency. The 2019 ACC/AHA prevention guideline executive summary presents Table 7, which details nonpharmacological interventions for hypertension. This table was reproduced from the 2017 ACC/AHA high blood pressure guideline. The guideline states that nonpharmacological interventions are recommended for adults with elevated blood pressure or hypertension, including those taking antihypertensive medications. Blood pressure categories and classification criteria appear in the guide to blood pressure ranges.

For dietary sodium, the guideline advises an optimal goal below 1,500 mg daily, aiming for at least a 1,000 mg daily reduction. Practical sodium reduction steps are detailed in the sodium guide. For weight management, the guideline advises aiming for ideal body weight, or at least a 1-kg reduction for adults who are overweight. The table says to expect about 1 mmHg lower systolic pressure for every 1 kg of weight lost. Evidence-based strategies for body weight reduction appear in our review of weight loss approaches.

For alcohol consumption, the guideline advises men who drink to consume no more than two standard drinks daily. Women who drink should have no more than one drink daily. One standard drink represents roughly 14 g of pure alcohol, typical in 12 oz of 5% beer, 5 oz of 12% wine, or 1.5 oz of 40% spirits.

What the DASH and Sodium Trials Found

Clinical trials evaluating the Dietary Approaches to Stop Hypertension (DASH) eating pattern lowered systolic blood pressure after eight weeks. In the original DASH trial published by Appel and colleagues (New England Journal of Medicine, 1997), 459 adults ate a control diet for three weeks. Participants had baseline systolic pressure under 160 mmHg and diastolic pressure between 80 and 95 mmHg. Investigators randomized participants to eight weeks of the control diet, a fruits-and-vegetables diet, or the combination DASH diet. Sodium intake and body weight were held constant across all arms. The combination diet lowered systolic pressure by 5.5 mmHg and diastolic pressure by 3.0 mmHg more than the control diet. Among the 133 participants with hypertension, the combination diet lowered systolic pressure by 11.4 mmHg and diastolic by 5.5 mmHg more than the control diet. For the 326 participants without hypertension, the combination diet lowered systolic pressure by 3.5 mmHg more than the control diet.

The subsequent DASH-Sodium trial published by Sacks and colleagues (New England Journal of Medicine, 2001) evaluated 412 participants across three sodium intake levels. Participants ate either a typical American diet or the DASH diet for 30 consecutive days at each sodium level. Compared with the control diet at high sodium, the DASH diet at low sodium lowered mean systolic pressure by 7.1 mmHg in participants without hypertension. In participants with hypertension, the mean systolic reduction reached 11.5 mmHg. Sacks and colleagues reported that reduced sodium and the DASH diet both lower blood pressure substantially, with greater effects in combination than singly.

The National Heart, Lung, and Blood Institute (NHLBI) DASH Eating Plan states that consuming 1,500 mg of sodium daily lowers blood pressure further than 2,300 mg daily. The NHLBI DASH research page says the original DASH study measured its results after 8 weeks. The DASH and DASH-Sodium results were measured after 8 weeks and 30 days of eating the diets, and the exercise trials ran for weeks to months. The largest drop in a single table row is about 11 mmHg systolic, and the trial that paired DASH with low sodium reported 11.5 mmHg in people with hypertension.

Which Exercise Lowers Blood Pressure Most

Isometric resistance exercise produced the largest systolic blood pressure reductions among all exercise modes evaluated in a network meta-analysis of randomized controlled trials. In a network meta-analysis of 270 randomized controlled trials covering 15,827 participants, Edwards and colleagues (British Journal of Sports Medicine, 2023) analyzed exercise interventions lasting at least two weeks. Isometric exercise training yielded resting blood pressure reductions of -8.24/-4.00 mmHg. Isometric training ranked first for lowering systolic blood pressure. The authors found that the isometric wall squat was the most effective sub-mode for systolic pressure reduction. Running was the most effective mode for lowering diastolic pressure. Dynamic resistance training lowered readings by -4.55/-3.04 mmHg across tested protocols. Aerobic training reduced resting pressure by -4.49/-2.53 mmHg. High-intensity interval training produced resting blood pressure reductions of -4.08/-2.50 mmHg across the analyzed trials. Combined training reduced resting blood pressure by -6.04/-2.54 mmHg.

The 2017 ACC/AHA table gives its own figures for each exercise type. The ACC/AHA table estimates that 90 to 150 minutes weekly of aerobic exercise lowers systolic pressure by 5 to 8 mmHg in adults with hypertension. Dynamic resistance training lowers systolic pressure by about 4 mmHg. Isometric handgrip training performed three times weekly lowers systolic pressure by approximately 5 mmHg. The trials in the Edwards analysis lasted at least 2 weeks, and the table's handgrip program runs 8 to 10 weeks.

Rapid Blood Pressure Reduction Claims in Clinical Studies

Blinded clinical trials show that device-guided breathing techniques do not reliably lower office blood pressure compared to active controls or standard care. In an individual-patient-data meta-analysis of blinded randomized trials lasting at least four weeks, Landman and colleagues (JAMA Internal Medicine, 2014) examined device-guided breathing. Five studies were selected, and data from two were not provided. The effect on office systolic blood pressure was 2.2 mmHg in favor of the control group, with a 95% confidence interval of -2.7 to 7.0 mmHg. Landman and colleagues reported that device-guided breathing did not lower office blood pressure compared with a sham procedure or music therapy. Because all trials had short follow-up, the authors stated that no clinical recommendations could be made.

A systematic review and meta-analysis by de Freitas Gonçalves and colleagues (Health Science Reports, 2022) evaluated slow breathing in people with hypertension. Device-guided slow breathing did not reduce systolic pressure compared with usual care. The systolic mean difference was -2.13 mmHg with a 95% confidence interval of -12.71 to 8.44 mmHg. The authors called non-device-guided slow breathing a new path for the future.

In a double-blind, sham-controlled trial, Craighead and colleagues (Journal of the American Heart Association, 2021) tested inspiratory muscle strength training. The trial enrolled adults aged 50 to 79 with systolic blood pressure of 120 mmHg or higher. Thirty-six participants completed thirty breaths daily, six days weekly, for six weeks. Casual systolic blood pressure fell from 135 to 126 mmHg in the training group. About 75% of the reduction remained six weeks after training stopped. Sham training produced no effect. This protocol was a six-week physical training regimen in a small trial.

None of the cited sources describes or tested a 60-second, 7-second or 3-minute trick. No study reviewed here tested drinking water or any specific juice to lower blood pressure. Among the sources cited here, the only drink-related change with a measured effect is cutting alcohol, about 4 mmHg systolic in adults with hypertension. A large randomized trial evaluating device-guided breathing against an active control with long follow-up would change this evaluation.

What the 2025 Guideline Recommends

The 2025 American College of Cardiology and American Heart Association guideline establishes an overarching blood pressure treatment goal below 130/80 mmHg for all adults. In a review of the 2025 guideline published by Healio (Troy, Blumenthal and Schott, 2025), six nonpharmacological interventions receive a class 1 strong recommendation. These class 1 interventions include weight loss, the DASH diet, a high-potassium diet, sodium reduction, alcohol cessation and exercise. Potassium-based salt substitutes receive a class 2a recommendation. Stress reduction receives a class 2b recommendation. The guideline encourages reaching a systolic pressure below 120 mmHg for individuals at elevated cardiovascular risk.

A summary in U.S. Pharmacist (Mahvan and colleagues, 2026) details specific lifestyle targets from the 2025 update. The sodium target advises reducing intake ideally below 1,500 mg daily. Potassium-based salt substitutes are recommended for patients who obtain most sodium from table salt, excluding people with chronic kidney disease. The guideline sets an initial target of at least 5% weight loss. Physical activity recommendations specify aerobic exercise complemented by resistance training. Stress-reduction strategies include meditation, deep-breathing techniques, or yoga. Healio words the alcohol guidance as alcohol cessation, while U.S. Pharmacist describes limiting consumption to two drinks daily for men and one for women.

In an analysis by Zhang and colleagues (Hypertension, 2025), stage 1 hypertension remains defined as systolic 130 to 139 mmHg or diastolic 80 to 89 mmHg. Additional diagnostic classifications appear in the overview of the 2025 blood pressure guidelines. The American College of Cardiology summary by Ebinger, Yang and Gianos (2025) adds that the 130/80 goal comes "with additional considerations."

When Medication Is Recommended

Cardiology guidelines recommend initiating antihypertensive medication when blood pressure reaches 140/90 mmHg or when stage 1 hypertension occurs alongside elevated cardiovascular risk. In an analysis of the 2025 guideline, Sayed and colleagues (American Journal of Preventive Cardiology, 2026) outline drug initiation thresholds. Clinicians receive a class I recommendation to start blood pressure medication at 140/90 mmHg or higher. Medication is also recommended at 130/80 mmHg or higher if 10-year cardiovascular risk reaches 7.5% or higher on the PREVENT equations. The same recommendation applies to patients with diabetes, chronic kidney disease, or established cardiovascular disease. The guide on how to lower cholesterol covers lowering LDL. High blood pressure also represents a diagnostic component of metabolic syndrome.

For adults with stage 1 hypertension and lower risk with PREVENT scores below 7.5%, the ACC guidance specifies a distinct trial period. Clinicians are recommended to start medication if three to six months of lifestyle changes fail to lower blood pressure below 130/80 mmHg. Zhang and colleagues identify this lower-risk stage 1 guidance as a new recommendation in the 2025 update. When medication is initiated, U.S. Pharmacist notes that single-pill combinations are preferred to enhance adherence. U.S. Pharmacist says combination therapy is typical for stage 2 hypertension. Lifestyle interventions continue alongside pharmacotherapy to support blood pressure management.

When a Reading Is an Emergency

A blood pressure measurement of 180/120 mmHg or higher accompanied by symptoms requires immediate emergency medical evaluation. According to the Cleveland Clinic (2026), a hypertensive crisis is very high blood pressure that happens without warning. It can be 180/120 millimeters of mercury (mm Hg) or higher. Cleveland Clinic identifies two distinct clinical categories. Severe hypertension, formerly called hypertensive urgency, occurs when blood pressure is very high without signs of organ damage. A hypertensive emergency occurs when blood pressure is very high and signs of organ damage appear. Target organs include the heart, eyes, brain, kidneys, or aorta.

Cleveland Clinic says to call 911 or your local emergency services number if your blood pressure is 180/120 mm Hg or higher and you have any symptoms, like chest pain, headache or vision changes. If blood pressure is 180/120 mmHg or higher without symptoms, Cleveland Clinic advises resting several minutes before retesting.

The NHLBI high blood pressure guide states that readings above 180/120 mmHg are dangerously high and require immediate medical attention. NHLBI says to call 9-1-1 if you have a sudden, severe headache, difficulty breathing, or sudden, severe pain in the chest, back or abdomen. Emergency symptoms also include numbness, weakness, sudden vision changes, or speech problems. Healio reports that under the 2025 guideline, hypertensive urgency is now termed severe hypertension. For readings above 180/120 mmHg without end-organ damage, guideline authors state that intravenous medications and emergency department referral are not recommended. Clinicians should attempt intensification of oral antihypertensive medications in an outpatient setting. This outpatient guidance applies to asymptomatic patients and does not alter instructions to seek emergency care when symptoms occur. To start lowering your blood pressure, pick one row of the ACC/AHA table above, such as cutting sodium by at least 1,000 mg a day, and work toward its goal.

What to Look For in a Blood Pressure Monitor

An upper-arm cuff is more accurate than a wrist model. Pick a clinically validated device with a cuff sized to your arm, and take readings seated after five minutes of rest. Models that store readings or sync to an app make it easy to share trends with your doctor.

iHealth Track Smart Upper Arm Blood Pressure Monitor with Wide Range Cuff that fits Standard to Large Adult Arms, Bluetooth Compatible for iOS & Android Devices

iHealth

View on Amazon →

Oklar Blood Pressure Monitor Upper Arm Monitors for Home Use BP Machine Sphygmomanometer with 2x120 Reading Memory Adjustable Arm Cuff 8.7"-15.7" Large Display with LED Background Light Storage Bag

Oklar

View on Amazon →